The fact
These medications reduce appetite, affecting fast-food sales, cinema revenues, and air transport logistics.
Novo Nordisk, the manufacturer of Ozempic, aims to demonstrate the effectiveness of these treatments against obesity.
Click the link to read an article on the topic: